Strides Pharma

Strides Pharma Science Q2 profit falls 46% to Rs 77 crore

Strides Pharma Science Q2 profit falls 46% to Rs 77 crore

Strides Pharma Science on Thursday reported 45.75 per cent decline in consolidated net profit at Rs 76.98 crore for the quarter ended Se...Read More

Strides Pharma to conduct bio-equivalence study on favipiravir in India

Strides Pharma to conduct bio-equivalence study on favipiravir in India

The drug is a generic version of Japan-based Toyama Chemical's Avigan and was initially developed to treat influenza in Japan. It has sho...Read More

Ex-Cipla honcho R Ananthanarayanan appointed CEO of Strides Pharma Science Ltd

Ex-Cipla honcho R Ananthanarayanan appointed CEO of Strides Pharma Science Ltd

"Ananth will succeed our founder and incumbent CEO Arun Kumar following his appointment as the new Chief Executive by the Board

Strides Pharma gets tentative nod from USFDA for pain-relieving drug

Strides Pharma gets tentative nod from USFDA for pain-relieving drug

New Delhi: Drug firm Strides Pharma Science on Wednesday said it has got tentative approval from US health regulator for Diclofenac Potas...Read More

Strides acquires USFDA approved manufacturing facility in US

Strides acquires USFDA approved manufacturing facility in US

Strides Pharma Science said the site has undergone several successful USFDA inspections and has no outstanding observations.

Strides Pharma Inc acquires USFDA approved manufacturing facility in US

Strides Pharma Inc acquires USFDA approved manufacturing facility in US

Strides Pharma Science said the site has undergone several successful USFDA inspections and has no outstanding observations

Free Press Journal

www.freepressjournal.in